Tevogen Inc. (TVGN) EBITDA
Tevogen Inc. (TVGN) EBITDA
- 2026-06-30: Basis Reported; EBITDA (m); Operating income -$5.66M; Depreciation and amortization (m).
- 2026-03-31: Basis Reported; EBITDA (m); Operating income -$5.40M; Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA (m); Operating income -$5.73M; Depreciation and amortization (m).
- 2025-06-30: Basis Reported; EBITDA (m); Operating income -$5.44M; Depreciation and amortization (m).
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-06-30 | Reported | (m) | -$5.66M | (m) | (m) | (m) | (m) | -$3.01M* | (m) | $3.28M | (m) | (m) |
|---|
| 2026-03-31 | Reported | (m) | -$5.40M | (m) | (m) | (m) | (m) | -$2.73M | (m) | $3.13M | (m) | (m) |
|---|
| 2025-09-30 | Reported | (m) | -$5.73M | (m) | (m) | (m) | (m) | -$3.65M* | (m) | $3.11M | (m) | (m) |
|---|
| 2025-06-30 | Reported | (m) | -$5.44M | (m) | (m) | (m) | (m) | -$3.19M* | (m) | $2.70M | (m) | (m) |
|---|
| 2025-03-31 | Reported | (m) | -$10.36M | (m) | (m) | (m) | (m) | -$3.31M | (m) | $3.20M | (m) | (m) |
|---|
| 2024-09-30 | Reported | (m) | -$6.09M | (m) | (m) | (m) | (m) | -$3.80M* | (m) | $3.26M | (m) | (m) |
|---|
| 2024-06-30 | Reported | (m) | -$8.60M | (m) | (m) | (m) | (m) | -$2.98M* | (m) | $4.12M | (m) | (m) |
|---|
| 2024-03-31 | Reported | (m) | -$29.52M | (m) | (m) | (m) | (m) | -$2.16M | (m) | $20.81M | (m) | (m) |
|---|
| 2023-09-30 | Reported | (m) | -$2.33M | (m) | (m) | (m) | $0.00* | -$1.80M* | (m) | $1.12M | (m) | (m) |
|---|
| 2023-06-30 | Reported | (m) | -$2.18M | (m) | (m) | (m) | $0.00* | -$2.22M* | (m) | $1.03M | (m) | (m) |
|---|
| 2023-03-31 | Reported | (m) | -$2.32M | (m) | (m) | (m) | $133.00K | -$2.18M | (m) | $1.35M | (m) | (m) |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2025-12-31 | Reported | (m) | -$26.14M | (m) | (m) | (m) | $64.44K | -$12.33M | (m) | $11.11M | (m) | $4.75K |
|---|
| 2024-12-31 | Reported | (m) | -$53.56M | (m) | (m) | (m) | (m) | -$12.00M | (m) | $31.03M | (m) | $1.75K |
|---|
| 2023-12-31 | Reported | (m) | -$8.84M | (m) | (m) | (m) | $133.00K | -$8.17M | (m) | $4.40M | (m) | (m) |
|---|